JPRN-jRCTs041180049已完成2 期
A before-after study of tolerance induction by very low-dose oral immunotherapy for peanut allergy - VLOIT study
atsume Osamu0 个研究点目标入组 40 人开始时间: 2019年2月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 <= 15age old（—）
- 性别
- All
入选标准
- •Patients who eliminate peanut. Patients with positive open label oral food challenge (exclude oral around symptom) less than or equal to 1.4 g of peanuts, which contained 35.7 mg peanut protein (only VLOIT group).
排除标准
- •Patients with uncontrollable asthma or atopic dermatitis. Patients with chronic urticaria. Patients who do immunotherapy of other foods within 2 hours before and after this treatment. Patients whom the doctor assesses ineligible.
研究者
相似试验
招募中
不适用
A before-after study of tolerance induction by very low-dose oral immunotherapy for peanut allergyfood allergyJPRN-UMIN000027102Hamamatsu University School of Medicine, department of pediatrics20
尚未招募
1 期
A prospective study of tolerance induction by continued very low-dose oral immunotherapy (VLOIT) for peanut allergyFood AllergyJPRN-UMIN000034808Hamamatsu University School of Medicine, department of pediatrics40
已完成
不适用
Study on the effect of oral tolerance induction by early ingestion of powdered milkFood allergyJPRN-UMIN000028846ational Hospital Organization Fukuoka Hospital200
已完成
不适用
Induction of tolerance through early introduction of peanut in high-risk childrePeanut allergy, peanut hypersensitivity, eczema, egg hypersensitivity, food hypersensitivityInjury, Occupational Diseases, PoisoningAllergy or hypersensitivityISRCTN94818122Immune Tolerance Network for National Institute of Allergy and Infectious Diseases480
进行中（未招募）
不适用
Comparative study of the efficacy and tolerance of intravenously administered azithromycin (1.5 g) given either as a single dose or over a 3 day period in patients with community-acquired pneumoniacommunity aquired pneumoniaEUCTR2005-000105-65-ATMedical University of Vienna, Department of Internal Med. I, Division of Infectious Diseases300